The board of directors of GlaxoSmithKline Bangladesh Limited has recommended 530 per cent cash dividend for the year ended on December 31, 2018.
The final approval of dividend will come during the annual general meetings (AGM) scheduled to be held on April 25 at Radisson Blu Chattogram Bay view, Chattogram, said an official disclosure on Wednesday.
The record for entitlement of interim cash dividend date is on March 21.
The multinational company has also reported earnings per share (EPS) of Tk 52.75 in the negative, net asset value (NAV) per share of Tk 104.11 and net operating cash flow per share (NOCFPS) of Tk 44.67 for the year ended on December 31, 2018 as against Tk 55.56, Tk 218.35 and Tk 117.74 respectively for the same period of the previous year.
There will be no price limit on the trading of the shares of the multinational company today (Wednesday) following its corporate declaration.
GlaxoSmithKline, which was listed on the DSE in 1976, disbursed 550 per cent cash dividend for the year ended on December 31, 2017.
Each share of the company closed at Tk 1405.50 on Tuesday at Dhaka Stock Exchange.
The company’s paid-up capital is Tk 120.46 million, authorised capital is Tk 200 million and the total number of securities is 12.04 million.
